| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | — |
| R&D Expense | $26.7M | -32.7% |
| SG&A Expense | $23.9M | -9.6% |
| Operating Income | -$53.3M | +19.3% |
| Interest Expense | $5.0M | -1.0% |
| Income Tax | $0 | — |
| Net Income | -$30.0M | +11.6% |
| EPS (Basic) | -$1.05 | +21.1% |
| EPS (Diluted) | -$1.05 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | -35.8% |
| Current Assets | $29.7M | -41.5% |
| Total Assets | $36.6M | -36.7% |
| Current Liabilities | $19.9M | +149.0% |
| Long-term Debt | $25.0M | -16.7% |
| Total Liabilities | $33.1M | +2.1% |
| Stockholders' Equity | $2.0M | -84.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.5M | +30.7% |
| Capital Expenditures | $268K | -78.2% |
| Investing Cash Flow | $19.8M | -33.7% |
| Financing Cash Flow | $13.6M | +5730.5% |
| Free Cash Flow | -$35.8M | +31.8% |
| +21.1% |